Mylan’s daclatasvir/sofosbuvir tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Desogestrel/Ethinylestradiol prequalified
M
WHO Prequalification Unit (PQT) added the below newproducts to its prequalified list:
First remdesivir prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Sandoz’ rituximab prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
First clofazimine prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list: